Fresenius Medical Care AG & Co. KGaA
HealthcareNYSE:FMS · New York Stock Exchange
+$0.66 today
Vol 0.47M · Avg 0.77M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $939.8M +26.8% | $740.9M +1.1% | $732.5M -18.1% | $894.3M -26.6% | $1.2B | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $1.4B -19.3% | $1.7B -0.6% | $1.8B -4.7% | $1.8B +13.2% | $1.6B | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | -$26.1M +64.0% | -$72.7M +40.5% | -$122.1M -194.5% | -$41.5M -161.7% | $67.3M | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $0 | $0 -100.0% | $32.5M | $0 | $0 | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | $132.8M -70.1% | $444.3M -20.8% | $561.3M +538.3% | -$128.1M -31.0% | -$97.8M | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | -$66.3M +9.7% | -$73.5M +51.6% | -$151.8M -225.3% | -$46.7M +71.4% | -$163.2M | $592.6M | $1.3B | $626.2M |
| Inventory | -$238.8M -321.4% | $107.9M +921.1% | -$13.1M +93.6% | -$204.3M -321.0% | -$48.5M | $1.0B | $1.2B | $1.1B |
| Accounts Payables | -$14.2M -109.1% | $155.6M +43.4% | $108.5M +130.4% | -$356.8M +2.0% | -$364.0M | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | $452.1M +77.8% | $254.3M -58.8% | $617.8M +28.8% | $479.7M +0.4% | $477.9M | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | $123.1M +126.3% | -$468.6M -43.2% | -$327.3M +17.3% | -$395.8M -22.6% | -$322.7M | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | $2.6B +7.9% | $2.4B -9.2% | $2.6B +21.3% | $2.2B -12.9% | $2.5B | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$879.2M -25.7% | -$699.4M -2.2% | -$684.6M +5.4% | -$724.0M +15.3% | -$854.4M | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | $223.3M -63.2% | $606.7M +342.8% | $137.0M +13226.8% | $1.0M +100.3% | -$381.7M | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | -$86.0M -5.5% | -$81.5M +20.4% | -$102.4M +3.1% | -$105.6M +18.2% | -$129.1M | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $80.2M +6.7% | $75.1M -16.1% | $89.6M +55.4% | $57.7M -60.1% | $144.5M | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $0 -100.0% | $14.1M -12.6% | $16.1M -55.4% | $36.2M +48.2% | $24.4M | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | -$666.2M -684.3% | -$84.9M +84.4% | -$544.2M +25.9% | -$734.7M +38.6% | -$1.2B | $4.8B | $6.4B | $5.1B |
| Debt Repayment | $767.1M +140.3% | -$1.9B -60.1% | -$1.2B -6.4% | -$1.1B -211.5% | -$358.9M | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $0 | $0 | $0 | $0 | $0 | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | -$562.2M | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | -$405.8M -16.2% | -$349.2M -6.3% | -$328.6M +16.9% | -$395.6M -0.8% | -$392.5M | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | -$1.2B -272.9% | -$315.0M +7.4% | -$340.1M -227.7% | -$103.8M +62.0% | -$273.0M | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | -$1.4B +46.5% | -$2.6B -38.2% | -$1.9B -14.9% | -$1.6B -57.9% | -$1.0B | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | $25.0M -4.7% | $26.2M +136.1% | -$72.6M -213.5% | -$23.2M -117.7% | $131.2M | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | $558.3M +330.8% | -$241.9M -257.7% | $153.4M +173.8% | -$207.9M -152.0% | $400.1M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | $1.7B +0.5% | $1.7B -13.2% | $1.9B +34.7% | $1.4B -11.7% | $1.6B | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Royalty Pharma plc
NASDAQ:RPRX
$23.71B
Hologic, Inc.
HOLX
$16.97B
Tenet Healthcare Corporation
NYSE:THC
$15.15B
Solventum Corporation
NYSE:SOLV
$13.53B
DaVita Inc.
NYSE:DVA
$13.46B
Smith & Nephew plc
NYSE:SNN
$12.97B
ICON Public Limited Company
NASDAQ:ICLR
$11.16B
Encompass Health Corporation
NYSE:EHC
$10.07B
Universal Health Services, Inc.
NYSE:UHS
$9.18B
Tempus AI, Inc.
NASDAQ:TEM
$8.29B
SEC Filings
Recent regulatory filings
No filings found.
Does FMS generate free cash flow?
Fresenius Medical Care AG & Co. KGaA (FMS) generated $1.70B of free cash flow in fiscal 2025.
How much operating cash flow does FMS produce?
Operating cash flow was $2.58B, before capital expenditures of $879.24M.
Explore More
Continue the stock analysis
Jump to another research area for this company.